NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for open-label trial


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Client-directed therapy technique drastically reduces divorce/separation rates
2009 NOV 28 ... according to a recently published study.According to the largest clinical trial with couples to date - which was co-authored by University of Rhode Island Human ...
Subject: University of Rhode Island
Price: $3.00
*
New findings from E. Poitevin and co-authors in the area of analytical science published
2009 NOV 25 ... "A single-laboratory validation (SLV) and a ring trial (RT) were undertaken to determine nine nutritional elements in food products by ...
Subject: Analytical Science
Price: $3.00
*
photoWALL Launches Globally, Creates New Live Social Network Category
2009 NOV 24 ... Flickr and Twitter.photoWALL is a free service. Its initial technology trial generated over a quarter million photos taken from over 100 countries. Users must have ...
Subject: photoWALL
Price: $3.00
*
Reports outline hypertension research from University of Colorado
2009 NOV 23 ... (Flolan ®) through continuous intravenous (IV) infusion in an uncontrolled open-label 3-year extension study following an initial randomized, controlled 12-week Study," ... State:CO, Country:United States, Alternative Medicine, Antihypertensive, Clinical Trial Research, Conventional Therapies, Drugs, Epoprostenol, Epoprostenol Sodium, Flolan, ...
Subject: Hypertension
Price: $3.00
*
Reports summarize medical law research from R.J. Flanagan and co-authors
2009 NOV 28 ... and sentenced to death. Leney was executed but Hannah Russell was respited because the trial judge, Sir Robert Graham, had doubts as to a direction he had given to the jury. The ...
Subject: Medical Law
Price: $3.00
*
Research conducted at S.J. Jarrett and co-authors has provided new information about ankylosing spondylitis
2009 NOV 23 ... (AS) selected for eligibility for anti-tumour necrosis factor therapy. In a 6-week open-label study, 22 patients with AS and eligible for biological therapy were treated with 90 mg ... Ankylosing Spondylitis, Anticancer Therapy, Biological Therapy, Biotherapy, Clinical Trial Research, Necrosis, Rheumatic Disease, Rheumatology, Treatment. This ...
Subject: Ankylosing Spondylitis
Price: $3.00
*
Research from Newcastle University yields new data on bullous pemphigoid
2009 NOV 23 ... Keywords: Country:United Kingdom, Anti-Infectives, Bullous Pemphigoid, Clinical Trial Research, Diagnosis, Diagnostics, Maxillofacial Surgery, Minocycline, Therapy, ...
Subject: Bullous Pemphigoid
Price: $3.00
*
Research from S. Lennon and co-authors reveals new findings on pharmacokinetics
2009 NOV 23 ... formulations of oseltamivir (prodrug) in healthy subjects. In this single-center, open-label, three-period crossover study, 24 healthy adult volunteers were randomized to receive ... (active metabolite) following oral administration of the market suspension, the clinical trial Suspension and the market capsule formulations of oseltamivir (prodrug) in healthy ...
Subject: Pharmacokinetics
Price: $3.00
*
Research on colon cancer described by scientists at University of Texas
2009 NOV 23 ... University of Texas. The researchers concluded: "From the randomized trial will determine the effectiveness of the intervention on our health-related outcomes as ...
Subject: Colon Cancer
Price: $3.00
*
Research results from H.E. Bays and co-authors update knowledge of body weight
2009 NOV 23 ... versus placebo (4 g/day of corn oil) + fenofibrate 130 mg/day (n = 83), and an 8-week open-label extension (n = 117), during which all subjects received P-OM3 + fenofibrate. who ... derived from an 8-week, randomized, double-blinded, placebo-controlled, parallel-group trial comparing P-OM3 4 g/day + fenofibrate 130 mg/day (n = 84) versus placebo (4 g/day of ...
Subject: Body Weight
Price: $3.00
*
Researchers from University of Maryland discuss findings in diabetes
2009 NOV 23 ... "The Stop Atherosclerosis in Native Diabetics Study (SANDS) was a randomized open-label clinical trial in type 2 diabetics designed to examine the effects of intensive ...
Subject: Diabetes
Price: $3.00
*
Scientists at University of Colorado publish research in arthritis
2009 NOV 23 ... to abatacept directly or after completing washout. In this international, 6-month, open-label trial, patients had active RA, an inadequate response to anti-TNF therapy for 3 months or ...
Subject: Arthritis
Price: $3.00
*
Studies conducted at S.J. Keteyian et al on heart failure recently published
2009 NOV 23 ... major cardiovascular (CV) events among subjects enrolled in a prospective clinical trial (HF-ACTION). We hypothesized that exercise testing would be safe, as defined by a rate ...
Subject: Heart Failure
Price: $3.00
*
Studies from Erasmus University update current data on pain syndromes
2009 NOV 23 ... function in patients with patellofemoral pain syndrome. Open label randomised controlled trial." "General practice and sport physician practice. Patients with a new ...
Subject: Pain Syndromes
Price: $3.00
*
Studies from University Medical Center add new findings in the area of schizophrenia quality of care
2009 NOV 23 ... differences between the SGAs and the FGA were minimal. In CUtLASS, a 12-month open-label trial, 277 patients were randomized to receive an FGA or a SGA. Again, efficacy was rather ...
Subject: Schizophrenia Quality of Care
Price: $3.00
*
Sun Microsystems Unveils New Desktop Virtualization Capabilities in Sun Ray Software 5
2009 NOV 24 ... VDI Software 3.1. Sun Ray Software 5 is available for purchase immediately and a free trial of the software can be downloaded at: http://www.sun.com/software/sunray/getit.jsp. "As ...
Subject: Sun Microsystems, Inc.
Price: $3.00
*
Telecommunications Software & Systems Group TSSG Launches the First Commercial Grade Open-Access IMS Test Network Hosted in Academia
2009 NOV 25 ... IMS network hosted at TSSG, enables technology providers worldwide to run tests, trial and validate IMS compliant products and functionality in a tested environment, and has ...
Subject: The Telecommunications Software & Systems Group
Price: $3.00
*
Timesys Provides the First Commercial Linux Support for the New Sitara Family of ARM Cortex-A8 Technology-based AM35x MPUs from Texas Instruments
2009 NOV 26 ... and AM3505 based designs."For a limited time, developers can obtain free trial access to LinuxLink, to quickly configure, build and evaluate embedded Linux on the ...
Subject: Timesys Corporation
Price: $3.00
*
Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer
2009 NOV 23 ... evaluation of TOK-001. The first clinical trial in that program, ARMOR1, is a Phase 1/2 open-label trial that will assess both safety and efficacy of once-daily treatment with TOK-001 in ...
Subject: Tokai Pharmaceuticals
Price: $3.00
*
Toumaz Technology Named Emerging Technology Company of the Year by National Microelectronics Institute
2009 NOV 23 ... applications. This month, Toumaz announced that it has begun a landmark clinical trial of its Sensium "digital plaster" wireless body monitor. The study, which is expected ...
Subject: Life Sciences
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login